Search research articles
Contact Us
Filters
Showing results (61-70 of 234) with videos related to
Page
of 24
Sort By:
International Journal of Oncology
|
September 6, 2007
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines
Cinzia De Marco, Nadia Zaffaroni, Elizabeth Comijn, et al.
World Journal of Gastrointestinal Oncology
|
December 17, 2010
Pathophysiology and biology of peritoneal carcinomatosis
Shigeki Kusamura, Dario Baratti, Nadia Zaffaroni, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 3, 2021
Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma
Cinzia Lanzi, Enrica Favini, Laura Dal Bo, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells
Francesco Paduano, Raffaella Villa, Marzia Pennati, et al.
Biomacromolecules
|
June 7, 2008
Novel PVA-based hydrogel microparticles for doxorubicin delivery
Francesca Cavalieri, Ester Chiessi, Raffaella Villa, et al.
The Prostate
|
December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis
Linda Orlandi, Mara Binda, Marco Folini, et al.
Plos One
|
December 24, 2011
Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo
Valentina Zuco, Michelandrea De Cesare, Raffaella Cincinelli, et al.
European Journal of Medicinal Chemistry
|
June 4, 2019
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives
Marta Recagni, Maria Laura Greco, Andrea Milelli, et al.
Journal of Translational Medicine
|
January 31, 2013
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors
Michele Sommariva, Michelandrea de Cesare, Alessandra Meini, et al.
Biochemical Pharmacology
|
March 9, 2010
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer
Marco Folini, Claudia Pivetta, Giuseppe Zagotto, et al.
Page
of 24
Search research articles
Search
Showing results (61-70 of 234) with videos related to
Sort By:
Page
of 24
International Journal of Oncology
|
September 6, 2007
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines
Cinzia De Marco, Nadia Zaffaroni, Elizabeth Comijn, et al.
World Journal of Gastrointestinal Oncology
|
December 17, 2010
Pathophysiology and biology of peritoneal carcinomatosis
Shigeki Kusamura, Dario Baratti, Nadia Zaffaroni, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 3, 2021
Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma
Cinzia Lanzi, Enrica Favini, Laura Dal Bo, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells
Francesco Paduano, Raffaella Villa, Marzia Pennati, et al.
Biomacromolecules
|
June 7, 2008
Novel PVA-based hydrogel microparticles for doxorubicin delivery
Francesca Cavalieri, Ester Chiessi, Raffaella Villa, et al.
The Prostate
|
December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis
Linda Orlandi, Mara Binda, Marco Folini, et al.
Plos One
|
December 24, 2011
Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo
Valentina Zuco, Michelandrea De Cesare, Raffaella Cincinelli, et al.
European Journal of Medicinal Chemistry
|
June 4, 2019
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives
Marta Recagni, Maria Laura Greco, Andrea Milelli, et al.
Journal of Translational Medicine
|
January 31, 2013
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors
Michele Sommariva, Michelandrea de Cesare, Alessandra Meini, et al.
Biochemical Pharmacology
|
March 9, 2010
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer
Marco Folini, Claudia Pivetta, Giuseppe Zagotto, et al.
Page
of 24